Patent · US Active

Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structure

US7693698B2 · kind B2 · utility

11Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2007
Grant dateApr 6, 2010
Priority date
Expiry dateApr 22, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2299/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This disclosure relates to LINGO-1 polypeptides, LINGO-1 polypeptide/ligand complexes, crystals of LINGO-1 polypeptides, crystals of LINGO-1 polypeptide/ligand complexes, and related methods and software systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.